(Total Views: 471)
Posted On: 03/10/2025 11:54:38 PM
Post# of 154593
Rube,
Because they were only announcing ‘promising survival observations,’ and ‘a small group of patients who failed treatment after developing metastatic disease survived more than 36 months after receiving leronlimab, are alive today, and currently identify as having no evidence of ongoing disease.’
Sounds good to me.
Chazzle
Because they were only announcing ‘promising survival observations,’ and ‘a small group of patients who failed treatment after developing metastatic disease survived more than 36 months after receiving leronlimab, are alive today, and currently identify as having no evidence of ongoing disease.’
Sounds good to me.
Chazzle
(0)
(0)
